Literature DB >> 28784847

α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.

Xi-He Zhang1,2, Xiao-Dong Lian1,2, Zheng-Xi Dai1, Hong-Yi Zheng1,3, Xin Chen1,2, Yong-Tang Zheng4.   

Abstract

Alternative splicing occurs frequently in many genes, especially those involved in immunity. Unfortunately, the functions of many alternatively spliced molecules from immunologically relevant genes remain unknown. Classical HLA-I molecules are expressed on almost all nucleated cells and play a pivotal role in both innate and adaptive immunity. Although splice variants of HLA-I genes have been reported, the details of their functions have not been reported. In the current study, we determined the characteristics, expression, and function of a novel splice variant of HLA-A11 named HLA-A11svE4 HLA-A11svE4 is located on the cell surface without β2-microglobulin (β2m). Additionally, HLA-A11svE4 forms homodimers as well as heterodimers with HLA-A open conformers, instead of combining with β2m. Moreover, HLA-A11svE4 inhibits the activation of NK cells to protect target cells. Compared with β2m and HLA-A11, the heterodimer of HLA-A11svE4 and HLA-A11 protected target cells from lysis by NK cells more effectively. Furthermore, HLA-AsvE4 expression was upregulated by HIV-1 in vivo and by HSV, CMV, and hepatitis B virus in vitro. In addition, our findings indicated that HLA-A11svE4 molecules were functional in activating CD8+ T cells through Ag presentation. Taken together, these results suggested that HLA-A11svE4 can homodimerize and form a novel heterodimeric complex with HLA-A11 open conformers. Furthermore, the data are consistent with HLA-A11svE4 playing a role in the immune escape of HIV-1.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28784847      PMCID: PMC5583747          DOI: 10.4049/jimmunol.1602183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  An mRNA surveillance mechanism that eliminates transcripts lacking termination codons.

Authors:  Pamela A Frischmeyer; Ambro van Hoof; Kathryn O'Donnell; Anthony L Guerrerio; Roy Parker; Harry C Dietz
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

Review 2.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

3.  CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.

Authors:  Tiing Jen Loh; Heegyum Moon; Sunghee Cho; Hana Jang; Yong Chao Liu; Hongmei Tai; Da-Woon Jung; Darren R Williams; Hey-Ran Kim; Myung-Geun Shin; D Joshua Liao; Jianhua Zhou; Wei Shi; Xuexiu Zheng; Haihong Shen
Journal:  Oncol Rep       Date:  2015-07-06       Impact factor: 3.906

4.  HnRNP A1 tethers KSRP to an exon splicing silencer that inhibits an erythroid-specific splicing event in PU.1-induced erythroleukemia.

Authors:  Alexandre Douablin; Mireille Deguillien; Osman Breig; Faouzi Baklouti
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  Identification of 4 different alternatively spliced HLA-A transcripts.

Authors:  L Norgaard; L Fugger; H O Madsen; A Svejgaard
Journal:  Tissue Antigens       Date:  1999-10

6.  Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo.

Authors:  Danillo G Augusto; Geraldine M O'Connor; Sara C Lobo-Alves; Sara Bass; Maureen P Martin; Mary Carrington; Daniel W McVicar; Maria Luiza Petzl-Erler
Journal:  Eur J Immunol       Date:  2015-05-06       Impact factor: 5.532

Review 7.  Hanging in the balance. KIR and their role in disease.

Authors:  Anthony P Williams; Andrew R Bateman; Salim I Khakoo
Journal:  Mol Interv       Date:  2005-08

8.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Authors:  Lena Fadda; Christian Körner; Swati Kumar; Nienke H van Teijlingen; Alicja Piechocka-Trocha; Mary Carrington; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

9.  HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Authors:  Rujun Song; Irene Lisovsky; Bertrand Lebouché; Jean-Pierre Routy; Julie Bruneau; Nicole F Bernard
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

Review 10.  Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

Authors:  Jason D Barbour; Uma Sriram; Stacy J Caillier; Jay A Levy; Frederick M Hecht; Jorge R Oksenberg
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

View more
  3 in total

Review 1.  A long road/read to rapid high-resolution HLA typing: The nanopore perspective.

Authors:  Chang Liu
Journal:  Hum Immunol       Date:  2020-05-01       Impact factor: 2.211

2.  Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.

Authors:  Ali Abouelghar; Reem Hasnah; Ghina Taouk; Mohamad Saad; Manale Karam
Journal:  Oncotarget       Date:  2018-06-05

3.  Alternative splicing of MR1 regulates antigen presentation to MAIT cells.

Authors:  Gitanjali A Narayanan; Abhinav Nellore; Jessica Tran; Aneta H Worley; Erin W Meermeier; Elham Karamooz; Megan E Huber; Regina Kurapova; Fikadu G Tafesse; Melanie J Harriff; David M Lewinsohn
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.